← All stocks

Skye Bioscience, Inc.

SKYE Net buying

CIK 0001516551 #5235 in the set updated 21 Sep 2026

Bought (120 mo)

$125.02B

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$6.97M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$6.97M

51 of 51 sales

Net

+$125.01B

+$125.01B against sales at will

By person

14 insiders · 60 transactions

11.7×

Punit Dhillon holds 11.7 times base salary in stock. $7.17M of shares against $610.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Punit Dhillon last reported holding, valued at $1.91, the price Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

DHILLON PUNIT

Chief Executive Officer

$100.00B (2)

$413.92K (2)

+$100.00B

3,755,544

10.60%

$7.17M

—

HEPPELL JAMES L

Director

$25.00B (1)

—

+$25.00B

500,000

1.41%

$955.00K

—

5AM Partners VII, LLC entity

10% owner

$16.53M (2)

$2.76M (21)

+$13.77M

8,979,503

25.35%

$17.15M

+112.2%

Schwab Andrew J.

Director

—

$2.76M (21)

−$2.76M

8,979,503

25.35%

$17.15M

—

Grayson Paul A.

Director

—

$432.06K (2)

−$432.06K

259,701

0.7332%

$496.03K

—

Emerald Health Sciences Inc. entity

10% owner

— (1)

$300.00K (1)

−$300.00K

169,407,901

—

$323.57M

+593.3%

ARSENAULT KAITLYN

Chief Financial Officer

—

$216.65K (2)

−$216.65K

166,342

0.4696%

$317.71K

—

Diep Tuan Tu

Chief Operating Officer

—

$97.72K (2)

−$97.72K

82,259

0.2322%

$157.11K

+7.1%

LYKOS COSMAS N

Chairman

—

4,599,400

12.98%

$8.78M

+24.3%

Lapham Reg Alexander

10% owner

—

3,787,500

10.69%

$7.23M

−3.1%

Murphy Brian Stuart

CEO, Chief Medical Officer

—

1,275,000

3.60%

$2.44M

+240.0%

Berecz Elizabeth

Chief Financial Officer

—

1,050,000

2.96%

$2.01M

+200.0%

Cesario Douglas A

CFO and Secretary

—

643,501

1.82%

$1.23M

—

Rai Sukhwinder Singh

Director

—

73,561

0.2077%

$140.50K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Emerald Health Sciences Inc.

29 Mar 2018

10% owner

Exercised, kept

20,000,000

$0.10

$2.00M

Emerald Health Sciences Inc.

29 Mar 2018

10% owner

Exercised, kept

12,335,000

$0.10

$1.23M

Emerald Health Sciences Inc.

24 Jan 2018

10% owner

Exercised, kept

1,781,250

$0.00

$1.78K

Show all 60 transactions →

What was left out

Form 4 filings counted 121

Amendments (4/A) skipped 6

Filings about a different issuer 0

Unreadable filings 0

Joint filings 6

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 51

Transactions with no price 1

Shares from compensation/vesting 1,333,352,036

Sales filed before the plan box existed 1

History held since 28 Mar 2017